Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...

We'll get a fresh look at SoFi's latest results when it reports its 2024 year-end earnings on Monday, Jan. 27. But in the ...

If you're looking for the relative safety of an S&P 500 ETF with a bit more punch, the Vanguard S&P 500 Growth ETF ( VOOG ...

The Mr. Cooper Group traces its roots way back to 1889 and is a specialist in home loan services. With a recent market value ...

Competition is already heating up, with many companies taking a unique approach to developing their quantum computers. One ...

AMD and Intel have both been AI afterthoughts compared to market leader Nvidia. Nonetheless, AMD's data center business has been growing strongly. Meanwhile, Intel offers a lot of hidden but valuable ...

For most of us, that age is between 66 and 67. If you start collecting your benefits earlier (as early as 62), your checks will be smaller, but you'll collect many more of them. Delaying beyond your ...

Going forward, SpaceX is likely to offer its gigantic Starship rocket as a competitor to New Glenn, and here, the advantage ...

Putting money into growth stocks with a lot of potential upside can deliver life-changing returns. Typically, however, t ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

Finding stocks that are among the top investments of the decade isn't easy. Many trends can rise and fall, causing some stocks to falter after a few years. However, one industry with obvious staying ...